Conestoga Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,571
| Closed | -$211K | – | 145 |
|
|
2021
Q4 | $211K | Buy |
+3,571
| New | +$177K | ﹤0.01% | 143 |
|
|
2021
Q1 | – | Sell |
-18,108
| Closed | -$667K | – | 149 |
|
|
2020
Q4 | $667K | Sell |
18,108
-345
| -2% | -$12.7K | 0.01% | 111 |
|
|
2020
Q3 | $643K | Buy |
18,453
+421
| +2% | +$14.8K | 0.01% | 110 |
|
|
2020
Q2 | $559K | Hold |
18,032
| – | – | 0.01% | 115 |
|
|
2020
Q1 | $558K | Hold |
18,032
| – | – | 0.02% | 95 |
|
|
2019
Q4 | $670K | Hold |
18,032
| – | – | 0.02% | 97 |
|
|
2019
Q3 | $615K | Hold |
18,032
| – | – | 0.02% | 85 |
|
|
2019
Q2 | $741K | Hold |
18,032
| – | – | 0.02% | 83 |
|
|
2019
Q1 | $727K | Hold |
18,032
| – | – | 0.02% | 83 |
|
|
2018
Q4 | $747K | Sell |
18,032
-1,082
| -6% | -$44.9K | 0.02% | 82 |
|
|
2018
Q3 | $799K | Hold |
19,114
| – | – | 0.02% | 84 |
|
|
2018
Q2 | $658K | Hold |
19,114
| – | – | 0.02% | 85 |
|
|
2018
Q1 | $644K | Buy |
19,114
+527
| +3% | +$18.1K | 0.02% | 85 |
|
|
2017
Q4 | $639K | Hold |
18,587
| – | – | 0.02% | 85 |
|
|
2017
Q3 | $630K | Hold |
18,587
| – | – | 0.03% | 80 |
|
|
2017
Q2 | $592K | Hold |
18,587
| – | – | 0.03% | 76 |
|
|
2017
Q1 | $603K | Sell |
18,587
-211
| -1% | -$6.65K | 0.04% | 73 |
|
|
2016
Q4 | $579K | Hold |
18,798
| – | – | 0.04% | 68 |
|
|
2016
Q3 | $604K | Hold |
18,798
| – | – | 0.04% | 64 |
|
|
2016
Q2 | $628K | Hold |
18,798
| – | – | 0.05% | 63 |
|
|
2016
Q1 | $529K | Hold |
18,798
| – | – | 0.04% | 63 |
|
|
2015
Q4 | $576K | Hold |
18,798
| – | – | 0.05% | 61 |
|
|
2015
Q3 | $560K | Hold |
18,798
| – | – | 0.04% | 60 |
|
|
2015
Q2 | $598K | Hold |
18,798
| – | – | 0.04% | 63 |
|
|
2015
Q1 | $620K | Hold |
18,798
| – | – | 0.04% | 65 |
|
|
2014
Q4 | $556K | Hold |
18,798
| – | – | 0.04% | 67 |
|
|
2014
Q3 | $527K | Sell |
18,798
-316
| -2% | -$8.87K | 0.04% | 59 |
|
|
2014
Q2 | $538K | Sell |
19,114
-526
| -3% | -$15K | 0.04% | 62 |
|
|
2014
Q1 | $599K | Sell |
19,640
-2,689
| -12% | -$80.2K | 0.04% | 71 |
|
|
2013
Q4 | $649K | Hold |
22,329
| – | – | 0.04% | 71 |
|
|
2013
Q3 | $609K | Sell |
22,329
-211
| -0.9% | -$5.74K | 0.05% | 61 |
|
|
2013
Q2 | $599K | Buy |
+22,540
| New | +$623K | 0.06% | 60 |
|
Other funds holding PFE
Conestoga Capital Advisors's PFE Position: Q1 2022 in Review
Conestoga Capital Advisors sold out of Pfizer (PFE) in Q1 2022, closing a stake of 3,571 shares — an estimated $211K sold.
Conestoga Capital Advisors first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $799K in Q3 2018. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- Conestoga Capital Advisors reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
- Conestoga Capital Advisors sold 3,571 Pfizer shares in Q1 2022, an estimated $211K.
- Conestoga Capital Advisors first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- Conestoga Capital Advisors's Pfizer position peaked at $799K in Q3 2018.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on Conestoga Capital Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.